H. Leopold

TL;DR: Investigation of the Kiel classification of non‐Hodgkin lymphomas found marked improvement of prognosis was solely possible by induction of complete remissions whereas in corresponding low‐grade malignant lymphomas also partial remissions were prognostically relevant.

TL;DR: This interim evaluation of a prospective multicenter study of the Kiel Lymphoma Study Group characterizes IC the less favorable lymphoma entity as evidenced by a more rapid lymph node enlargement, by aHigher incidence of constitutional symptoms and of marked anaemia, and by a higher percentage of patients requiring early treatment.

TL;DR: Survival of patients with NHL of low-grade malignancy significantly exceeds that of patientsWith NHL of high-grademalignancy, and different initial slope of survival curves shows that this latter group of NHL is not homogeneous with regard to prognosis.

TL;DR: Durch die Kiel-Klassifikation wurde eine Neuordnung der Non-Hodgkin-Lymphome in distinkte, auch klinisch-prognostisch differenzier-bare Lymphom-Entitaten erreicht, auf die unabhangig von den bisherigen Therapiestrategien langfristig geringe Beeinflusbarkeit dieser Erkrank

TL;DR: Patients with immunoblastic lymphoma presented more frequently with a reduced performance status and showed a poorer response to radio- and chemotherapy resulting in a worse prognosis discernible after the first year of follow-up.